PNOC 029, "Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
November 30, 2023
End Date
June 30, 2024
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
November 30, 2023
End Date
June 30, 2024